Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8581 |
High Similarity |
NPD1653 |
Approved |
0.8194 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8137 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8112 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8112 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7987 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7899 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7842 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7834 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7808 |
Intermediate Similarity |
NPD447 |
Suspended |
0.775 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.773 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7722 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7636 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD37 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7436 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7436 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7436 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7434 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7389 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7378 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7372 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7343 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD4626 |
Approved |
0.732 |
Intermediate Similarity |
NPD5762 |
Approved |
0.732 |
Intermediate Similarity |
NPD5763 |
Approved |
0.731 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7299 |
Intermediate Similarity |
NPD228 |
Approved |
0.7296 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7296 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7294 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2237 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD411 |
Approved |
0.7248 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7246 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7212 |
Intermediate Similarity |
NPD919 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD3225 |
Approved |
0.719 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7184 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7172 |
Intermediate Similarity |
NPD9717 |
Approved |
0.717 |
Intermediate Similarity |
NPD2676 |
Approved |
0.717 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD2675 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7132 |
Intermediate Similarity |
NPD290 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7091 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7055 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD3111 |
Phase 1 |
0.7037 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD2796 |
Approved |
0.703 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7029 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7024 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD1933 |
Approved |
0.6968 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD3748 |
Approved |
0.6957 |
Remote Similarity |
NPD2684 |
Approved |
0.6954 |
Remote Similarity |
NPD7039 |
Approved |
0.6954 |
Remote Similarity |
NPD7095 |
Approved |
0.6954 |
Remote Similarity |
NPD7240 |
Approved |
0.6954 |
Remote Similarity |
NPD7038 |
Approved |
0.6951 |
Remote Similarity |
NPD5090 |
Approved |
0.6951 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD5089 |
Approved |
0.6939 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD1608 |
Approved |
0.6937 |
Remote Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1240 |
Approved |
0.6928 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6918 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.691 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.691 |
Remote Similarity |
NPD6842 |
Approved |
0.691 |
Remote Similarity |
NPD6841 |
Approved |
0.6908 |
Remote Similarity |
NPD1048 |
Approved |
0.6894 |
Remote Similarity |
NPD1578 |
Phase 2 |
0.6889 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6879 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6879 |
Remote Similarity |
NPD7843 |
Approved |
0.6879 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD8313 |
Approved |
0.6875 |
Remote Similarity |
NPD7644 |
Approved |
0.6875 |
Remote Similarity |
NPD8312 |
Approved |
0.6867 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6864
|
Remote Similarity |
NPD6746 |
Phase 2 |